Loss of MTUS1 in gastric cancer promotes tumor growth and metastasis

Neoplasma

Volumn 61, Issue 2, 2014, Pages 128-135

  Li, X ^a,b   Liu, H ^c   Yu, T ^d   Dong, Z ^a   Tang, L ^a   Sun, X ^a  

^a SICHUAN UNIVERSITY   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Gastric cancer; Metastasis; MTUS1; Proliferation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INVASION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FLUORESCENCE MICROSCOPY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INCIDENCE; LYMPH NODE METASTASIS; METASTASIS; MITOCHONDRIAL TUMOR SUPPRESSOR GENE; MOUSE; NICK END LABELING; NONHUMAN; OVERALL SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM; STOMACH CANCER; TUMOR GROWTH; TUMOR VOLUME; WOUND HEALING;

GASTRIC CANCER, MTUS1, PROLIFERATION, METASTASIS;

ANIMALS; CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84893173043     PISSN: 00282685     EISSN: 13384317     Source Type: Journal    
DOI: 10.4149/neo_2014_018     Document Type: Article

References (27)

1. POLK DB, PEEK RM. Helicobacter pylori: gastric cancer and beyond. Nature Reviews Cancer 2010; 10: 403-14. http://dx.doi.org/10.1038/nrc2857
2. TSUGANE S, SASAZUKI S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007; 10: 75-83. http://dx.doi.org/10.1007/s10120-007-0420-0
3. YOSHIDA T, ONO H, KUCHIBA A, SAEKI N, SAKAMOTO H. Genome-wide germline analyses on cancer susceptibility and GeMDBJ database: Gastric cancer as an example. Cancer science 2010; 101: 1582-9. http://dx.doi.org/10.1111/j.1349-7006.2010.01590.x
4. BANDO E, YONEMURA Y, TAKESHITA Y, TANIGUCHI K, YASUI T, et al. Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma. American journal of surgery 1999; 178: 256. http://dx.doi.org/10.1016/S0002-9610(99)00162-2
5. SASAKO M, SANO T, YAMAMOTO S, KUROKAWA Y, NASHIMOTO A, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. New England Journal of Medicine 2008; 359: 453-62. http://dx.doi.org/10.1056/NEJMoa0707035
6. GONZALEZ CA, AGUDO A. Carcinogenesis, prevention and early detection of gastric cancer: Where we are and where we should go. International Journal of Cancer 2012; 130: 745-53. http://dx.doi.org/10.1002/ijc.26430
7. XIONG P, LI YX, TANG YT, CHEN HG. Proteomic Analyses of Sirt1-Mediated Cisplatin Resistance in OSCC Cell Line. The Protein Journal 2011; 30: 499-508. http://dx.doi.org/10.1007/s10930-011-9354-9
8. GAYTHER SA, GORRINGE KL, RAMUS SJ, HUNTSMAN D, ROVIELLO F, et al. Identification of germ-line E-cadherin mutations in gastric cancer families of European origin. Cancer research 1998; 58: 4086-9.
9. GARCiA I, VIZOSO F, MARTiN A, SANZ L, ABDEL-LAH O, et al. Clinical significance of the epidermal growth factor receptor and HER2 receptor in resectable gastric cancer. Annals of surgical oncology 2003; 10: 234-41. http://dx.doi.org/10.1245/ASO.2003.05.010
10. KURAYOSHI M, OUE N, YAMAMOTO H, KISHIDA M, INOUE A, et al. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion. Cancer research 2006; 66: 10439-48. http://dx.doi.org/10.1158/0008-5472.CAN-06-2359
11. KIRIKOSHI H, SEKIHARA H, KATOH M. Up-regulation of Frizzled-7 (FZD7) in human gastric cancer. International journal of oncology 2001; 19: 111.
12. DI BM, BIECHE I, DESHAYES F, VACHER S, NOUET S, et al. Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene 2006; 380: 127-36. http://dx.doi.org/10.1016/j.gene.2006.05.021
13. RODRIGUES-FERREIRA S, DI TOMMASO A, DIMITROV A, CAZAUBON S, GRUEL N, et al. 8p22 MTUS1 gene product ATIP3 is a novel anti-mitotic protein underexpressed in invasive breast carcinoma of poor prognosis. PloS one. 2009; 4: e7239. http://dx.doi.org/10.1371/journal.pone.0007239
14. SMOOT D, RESAU J, NAAB T, DESBORDES B, GILLIAM T, et al. Adherence of Helicobacter pylori to cultured human gastric epithelial cells. Infection and immunity. 1993; 61: 350-5.
15. YE H, PUNGPRAVAT N, HUANG B-L, MUZIO LL, MARIGGIÒ MA, et al. Genomic assessments of the frequent loss of heterozygosity region on 8p21. 3~ p22 in head and neck squamous cell carcinoma. Cancer genetics and cytogenetics 2007; 176: 100-6. http://dx.doi.org/10.1016/j.cancergencyto.2007.04.003
16. LI Z, ZHAO X, BAI S, WANG Z, CHEN L, et al. Proteomics identification of cyclophilin a as a potential prognostic factor and therapeutic target in endometrial carcinoma. Molecular & cellular proteomics 2008; 7: 1810-23. http://dx.doi.org/10.1074/mcp.M700544-MCP200
17. XU AG, LI SG, LIU JH, GAN AH. Function of apoptosis and expression of the proteins Bcl-2, p53 and C-myc in the development of gastric cancer. Apoptosis 2001; 17: 6.
18. UEMURA N, OKAMOTO S, YAMAMOTO S, MATSUMURA N, YAMAGUCHI S, et al. Helicobacter pylori infection and the development of gastric cancer. New England Journal of Medicine 2001; 345: 784-9. http://dx.doi.org/10.1056/NEJMoa001999
19. CAREN H, KRYH H, NETHANDER M, SJOBERG RM, TRÄGER C, et al. High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset. Proceedings of the National Academy of Sciences 2010; 107: 4323-8. http://dx.doi.org/10.1073/pnas.0910684107
20. EL AT, BRUCHMANN M, ZUSTIN J, ISBARN H, HELLWINKEL OJ, et al. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer. Clinical Cancer Research 2010; 16: 56-64. http://dx.doi.org/10.1158/1078-0432.CCR-09-1423
21. CALIFANO D, PIGNATA S, PISANO C, GREGGI S, LAURELLI G, et al. FEZ1/LZTS1 protein expression in ovarian cancer. Journal of cellular physiology 2010; 222: 382-6. http://dx.doi.org/10.1002/jcp.21962
22. WITTINGER M, VANHARA P, EL-GAZZAR A, SAVARESEBRENNER B, PILS D, et al. hVps37A status affects prognosis and cetuximab sensitivity in ovarian cancer. Clinical Cancer Research 2011; 17: 7816-27. http://dx.doi.org/10.1158/1078-0432.CCR-11-0408
23. DI BM, PINEAU P, NOUET S, BERHOUET S, SEITZ I, et al. Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma. Molecular and cellular endocrinology 2006; 252: 207-15. http://dx.doi.org/10.1016/j.mce.2006.03.014
24. FRANK B, BERMEJO JL, HEMMINKI K, SUTTER C, WAPPENSCHMIDT B, et al. Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk. Carcinogenesis 2007; 28: 1442-5. http://dx.doi.org/10.1093/carcin/bgm033
25. LOUIS SN, CHOW L, REZMANN L, KREZEL MA, CATT KJ, et al. Expression and function of ATIP/MTUS1 in human prostate cancer cell lines. The Prostate 2010; 70: 1563-74. http://dx.doi.org/10.1002/pros.21192
26. DING X, ZHANG N, CAI Y, LI S, ZHENG C, et al. Downregulation of tumor suppressor MTUS1/ATIP is associated with enhanced proliferation, poor differentiation and poor prognosis in oral tongue squamous cell carcinoma. Molecular Oncology 2011; 6: 73-80. http://dx.doi.org/10.1016/j.molonc.2011.11.002
27. MOLINA A, VELOT L, GHOUINEM L, ABDELKARIM M, BOUCHET BP, et al. ATIP3, a novel prognostic marker of breast cancer patient survival, limits cancer cell migration and slows metastatic progression by regulating microtubule dynamics. Cancer research 2013; 73: 2905-2915. http://dx.doi.org/10.1158/0008-5472.CAN-12-3565